Clinical Practice Guidelines Example Implmentation Guide - Hepatitis B Vaccination
1.0.0 - ci-build
Clinical Practice Guidelines Example Implmentation Guide - Hepatitis B Vaccination - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Official URL: http://cqframework.org/cpg-example-hepb/ImplementationGuide/cqframework.cpg-example-hepb | Version: 1.0.0 | |||
Active as of 2024-11-18 | Computable Name: CPGHepatitisBVaccinationExample |
This example describes a subset of the Hepatitis B (Hep B) immunization schedule for adults who are 18 years or older and have not yet been vaccinated for Hep B. It is provided for demonstration purposes and not intended to be a complete representation of all of the Hep B immunization schedule logic.
By the age of 18, many patients will have already received their entire Hep B series of shots during early childhood. The logic described here applies to patients >= 18 years of age who are unvaccinated and at risk for HBV infection, or are requesting protection from HBV infection. More information about Hepatitis B vaccination recommendations for adults can be found in the CDC MMWR Vol.67 / No.1 : Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices and, for adjuvant vaccine, in the April 2018 Recommendations for the use of adjuvanted hepatitis B vaccine (Heplisav-B, Dynavax). In addition, the Immunization Action Coalition has a good overview.
The logic described here assumes the following parameters:
{ "coding" : [ { "system" : "http://hl7.org/fhir/sid/cvx", "code" : "189" } ] }
in the http://hl7.org/fhir/ValueSet/vaccine-code Value Set. If a different Hep B vaccine other than the Hep B adjuvanted product is administered or preferred, other logic not represented in this example applies.For adults >= 18 years of age who have not received any prior doses of Hep B and is indicated to receive a Hep B shot, the Hep B adjuvanted vaccine (CVX 189) may be administered according to this logic as follows.
For the first dose:
For the second dose: